BMPR2 and pulmonary arterial hypertension: In addition, we and others have identified mutations in the bone morphogenetic protein type 2 receptor (BMPR2) and SMAD genes, which result in the excessive proliferation of pulmonary artery smooth muscle cells and the attenuation of apoptosis, which contribute to the pathogenesis of PAH [2,3,4].